Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
PDLI similar filings
- 20 Dec 10 U.S. Patent and Trademark Office Terminates Interference Proceeding
- 10 Dec 10 Departure of Directors or Certain Officers
- 1 Dec 10 PDL BioPharma Provides Fourth Quarter 2010 Revenue Guidance of $74 Million
- 16 Nov 10 Regulation FD Disclosure
- 10 Nov 10 PDL BioPharma Announces Third Quarter 2010 Financial Results
- 5 Nov 10 PDL BioPharma Completes Exchange to Retire $92.0 Million of
- 2 Nov 10 Regulation FD Disclosure
Filing view
External links
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg01.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg02.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg03.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg04.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg05.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg06.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg07.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg08.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg09.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg10.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg11.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg12.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg13.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg14.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg15.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg16.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg17.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg18.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg19.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg20.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg21.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg22.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg23.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg24.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg25.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg26.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg27.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg28.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg29.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg30.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg31.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg32.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg33.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg34.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg35.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg36.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg37.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg38.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg39.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg40.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg41.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg42.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg43.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg44.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg45.jpg)
![](https://capedge.com/proxy/8-K/0001144204-10-061218/ex99-1pg46.jpg)